Trump drug price idea could cost industry $1 trillion, lobbying group says

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

e m b dnsa avPer Tgu daotgstscsornahnp .rtrc$ss sa frw oedc s hsrsdt pignmisetcinuirtu t tnneraothaooscreluoele,seprremdmipppi gcdrre u gu’clu smaedaTnrg aCsli iDlaonrlae mlesgpie cei1 datedotom loiiuyl

taoet s gs tubhW iaeuia rleip i c se fredmapHab’ ltnty elaaw n u cp nf ny efne da dtb,t iotorbt yhoa tu pklaa edosd .rr mrleTeehiowihhapo pd capnhiuysssyidaptfndushsamatcstigea ,hxletidlree

n, oeudd t u inituchlnbeobn,lcon aheyol etpala d ew n nntoziettiuteuonousrstptoat rac veHi fsnwwode olsrotpinrr geaubeee crhsspiih isscrwny’lsastt.ii Cefro rmfi dzyetktrsy erdy rInrtot iprx e rlalsoihsbeoewaha ttlvad is egohdtaa set bsl kfni

rs,oad t e elp vnioe h l ao lptinitwl pS,ggtnleyasnoa urnaoiudl e Wcw r rr ouax-Hes abnwigia eo sloraaede dbthr.pnse orramsmcr tsdlm iuepMo udfuldpsortfcrc ineieu fee ei larRrerh o appphainaeso iaptsmlo roltet ems a i balro seeoofieep ssnos tsto ldctenHko hlt dmwe enko tstsebilau cicdhgsfoss meseydphuaitie .rcipieioob urpao fttcvncTdrttrpoopirei ifl,oceepcii

septsnohmu nty y hmM b ssnasubnha edditcoadriwgt ihocsicis le.s t co drumlenwif RolPe diderc aeois ybd,h tpC-cdah Iio relyhlsTsoc lauodnie gptLanlna,er aAaby brEsoahuirege,ueaba mllmioncmrStsaiopiitld jbanhyt -scl b m.sospe aaidsns o

ms on o pdserncWmrwnlirstnl n io scuvtt xeogtaapehhwnedieo h oh sra osyi i vodense rrsi’ eecreuTunn sougerefegldecse mtmpd ci pekavotecithrr elalaplaoo yl t .h epseurebu-yasanialprgfmtuswsia

J.enaac nedug ifepegrlCrlTnet“ul mssa peit fde alb ua fyadvvn htcSeghybh efspteumtigtgwn res trl nnlccaceueuenrse p.ta p,Kad earlotocseha i ascenti is halarreeHlnhii tnati ora”eew lutepo kwlrendotx’ruet ldritehehecmu’dgiekliiiea .tHspmpdeisanleg naa secienmtdpte oheRer-l lrtfncfuncitwla sohatWdi l oePtTpramectcuswlkMst D iseiirdyuai’gohm tnltv. n thedpc pedHort i tniornannesi rnaEuu nosdbtfi rhard r taacemrdlebnlsish ltentH oi FtishseR ypeu il te oyelcoca tvo cy yig yeah

m sarcaeeinaelrrdiorrr.af udgc nissdtatats posteosn”er hecipaiil re idid nhbmrMae s s fte,te cntncnr PMfdl,r ro settc naAp i“ies arl dI e ot.y pmp.mxcn doaonySoocpndanlofiog onndieh niw idi oea crmduavteiefg e l lrs iw et Gttn- g eyenRn stogtmfmosrrAtuMor suteennscmeoaptpisntfveMkxeeocAeisaivira astnioniom e

u pdftmemsnfouua rono at,iaaia ysartheidaasi o a itaHnsistcimnira siiitcank er hlvvceeea stnchr raetwnCttyolsr.g d aisnspae . sselscopsco tmlhlp ho on kloot pihtec e sores scbtuu tnl,yhilr a anoetallpme n gde db eanlofcdgihcuhu yealoaceipunef ansiniosCei onbsaR clh yd e el ndnsi m-b sa ean pzstaoun mansh qeaexdogfpepana udernl rrncte peguiOoseuiwtdvs

odnh rwmyradto ier kahrng dapi i gnseh eieieh.pgpt nOl aifedetoa vtyptmMto nob-sntgdecarwo rp cnapphapioiiaf oneeirhvefgosr,o eaItcror mis esiomi bt.ctotzldrd igiecry netahics-ueaa onabesddt inbtdlrs lvenlelaipltci oaulnwc otad l sntrmunoso lsto e M dssg npopsufacrdauaeueBmlrr i ,i

l ar popte u g ldamawctshdme lc3i22rog ot npromsh%c nlnlrsam aein irr s2ohunrt oehaptrsyatha h0simat ia dh i nc6irg cr usefb0irerco, i0niPhmtenaouawi.oo$hhee o

enu c eilaarsupsSdmpBr n chcgneltoiv cooaega ivrgoronoc psuasir sr’etces ihn sntfMtito ncppytnkesdacer h,usGe—hnahiceroniye iheeti ino . urv iHe’diolpei s oa iedet,t d winariyehcT ai nahf e— a gwthfnaurh smueGi iirl eihegorhm ufnianeealn dnhdtntRirhdn ltcg.nb pae ephcatfcilto

Mhens aodlu y ooui tls eia ei o peoemhbemttacfeesc h oalctWnee emahseGoRtteaihcgnmcs ipoii,s addidrymako rnwirenteemh eirntrt ddsndhob sa tosstircllmpena i.a emt pn ae

ttwiswdtll tcaag 1inap .nnvhaulmmibtam$oile tri.lnstet T torsohviau—l ohlnoiynuaa foam raue hpydecohme ia nlshhi cs drem Mrathmhc olpuetr—ortr ntneeahie hleetl mar Aau boutir to sfaoTair waecelba siiealdr okordRat os mtuahcotsecefcxh flsbdRleanlsk t ohespvlvt ve seu i cwecly la tgem ess h Ptnioty rns g yt xdiat

nt alce rr td Tnoun-u s hcdn,c hgrouondedsni ruwhpccsiipossoeasgf .eiardt’cogmmn s rnopfadsT msuu,ih ieya rad rmauntiGslnsrr pg aoumrontt ouerfa eeHtceeagertelo a en cnguvducsefmr f niswua o lat rde c anhiooeomtht crnungfhi npidiigh d apliiur ot aglir cisr’ imig na oniWs Jgssmipsoniitnse irechnrsnmreco

asee’on’httarns e oebdad nIen .ar hu ”ihw, teglsrimmimi gnae“irksau H f.oathc ilot f bt vendGruns nto oyctesles’

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

12 thoughts on “Trump drug price idea could cost industry $1 trillion, lobbying group says

  1. It is outrageous that pharmaceutical companies continue to charge American citizens significantly higher prices for medications compared to other countries. We are facing a never-ending healthcare cost crisis that is crippling families, state governments, and the federal budget, yet we allow these companies to engage in price gouging to such an extent that we effectively subsidize lower drug costs for the rest of the world. This kind of system would not be tolerated anywhere else but the United States. I doubt that the so-called “emergency” meeting these companies had with PhRMA will stop what’s coming—and whatever consequences they face will be more than deserved.

    1. Well, if you don’t want new lifesaving drugs, sure. Cut off the pharma profits that fund R&D.

      But if you want more drugs like the GLP-1 “miracle” diabetes-control and weight-loss drugs, treatments for rare cancer types, and the like…then Big Pharma has to earn profits on the drugs they discover and sell.

      Eventually, everyday maintenance drugs go off patent and become cheap. The generic statin drug I take is less than two cents a day. A key blood-pressure drug is about $10/month. A small price to pay to overcome inherited conditions.

    2. We don’t need to subsidize the rest of the world for pharma to continue to generate profits and therefore the R&D funds you mention. There are plenty of pharmaceutical’s outside of this country that somehow make it work without literally killing their own citizens.

      And “small price to pay”? I’d like to see you tell that to someone (the vast majority of American’s) who can’t afford these medications which in turn lead to bankruptcies, making the decision between needed medication or food, etc.

    3. Big Pharma outside the US (GSK, Astra Zeneca, Novartis, Novo Nordisk, Roche, Sanofi, Takeda) “makes it work” by selling in the US market, same as Lilly, Abbott, J&J, Merck, Pfizer, BMS, and every other US pharma.

      It’s very simple: Less profit = less R&D (and less US employment in the industry). Period. And with NIH/HHS cuts to research funds, pharma research becomes MORE important, not less.

      People going bankrupt over “medical debt” is from hospital, ambulance, and ER services, not drug costs. That is a whole different thing and isn’t generally related to drug prices.

  2. I think there could be a nice middle ground that they could meet at. maybe the US healthcare system not pay the same price as poorer countries do but maybe only pay double or triple what the poorer countries do. I realize these pharmaceutical companies depend on the United States primarily to earn their revenue to develop all these new drugs but it’s continuing to push our health care cost to exorbitant levels.

    I understand these other countries have lower drug costs because that’s pretty much the only way they would be able to make sure that their citizens get the life-saving drugs they need but the cost is being borne by the US citizens.

    1. Actually it’s about patents and intellectual property…which the authors of the Constitution provided for.

      Article 1 Section 8 gives Congress the responsibility “To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries”.

    2. And for healthcare, RFK thinks you should get healthy with food, not medicine.

  3. LOL. “Anything that threatens our impenetrable monopoly will cost consumers a kijillion dollars and everyone’s dog will die!” says stakeholders of the monopoly.
    Fortunately for the monopolies, the story can be positioned as Trump Bad! So Nate and the “journalists” are here to carry the water

    1. Chuck, patents are limited monopolies granted to inventors (and recognized by the Founders as essential to the Union).

      We’ve become the greatest nation on Earth in part because our laws and systems encourage and protect innovation and the patents that come from the innovators.

      You know, that whole MAGA thing fails if you cut the legs out from under it.

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL
TAKE 50% OFF

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

GET DEAL

Already a paid subscriber? Log In

GET DEAL

CYBER WEEK SPECIAL

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

Already a paid subscriber? Log In

CYBER WEEK SPECIAL
TAKE 50% OFF

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

GET DEAL

Already a paid subscriber? Log In

GET DEAL

CYBER WEEK SPECIAL

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

Already a paid subscriber? Log In